Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Malignant Melanoma

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 65 articles:
HTML format
Text format



Single Articles


    July 2019
  1. SONG Y, Bruce AN, Fraker DL, Karakousis GC, et al
    Isolated limb perfusion and infusion in the treatment of melanoma and soft tissue sarcoma in the era of modern systemic therapies.
    J Surg Oncol. 2019 Jul 2. doi: 10.1002/jso.25600.
    PubMed     Text format     Abstract available


    June 2019
  2. O'NEILL CH, Scoggins CR
    Melanoma.
    J Surg Oncol. 2019 Jun 27. doi: 10.1002/jso.25604.
    PubMed     Text format     Abstract available


    March 2019
  3. BARTLETT EK
    Current management of regional lymph nodes in patients with melanoma.
    J Surg Oncol. 2019 Mar 24. doi: 10.1002/jso.25442.
    PubMed     Text format    


  4. PAVRI SN, Han G, Khan S, Han D, et al
    Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25445.
    PubMed     Text format     Abstract available


  5. KLEMEN ND, Han G, Leong SP, Kashani-Sabet M, et al
    Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit.
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25444.
    PubMed     Text format     Abstract available


  6. SINNAMON AJ, Neuwirth MG, Song Y, Schultz SM, et al
    Multispectral photoacoustic imaging for the detection of subclinical melanoma.
    J Surg Oncol. 2019 Mar 15. doi: 10.1002/jso.25447.
    PubMed     Text format     Abstract available


  7. CIANCIO F, Elia R, Nacchiero E, Perrotta RE, et al
    Current management of regional lymph nodes in patients with melanoma.
    J Surg Oncol. 2019 Mar 12. doi: 10.1002/jso.25443.
    PubMed     Text format    


    February 2019
  8. PEREZ MC, Sun J, Farley C, Han D, et al
    Management of intussusception in patients with melanoma.
    J Surg Oncol. 2019 Feb 7. doi: 10.1002/jso.25393.
    PubMed     Text format     Abstract available


  9. READ T, Lonne M, Sparks DS, David M, et al
    A systematic review and meta-analysis of locoregional treatments for in-transit melanoma.
    J Surg Oncol. 2019 Feb 7. doi: 10.1002/jso.25400.
    PubMed     Text format     Abstract available


    January 2019
  10. GERKEN ALH, Dobroschke J, Reissfelder C, Hetjens S, et al
    Tissue sealants for the prevention of lymphoceles after radical inguinal lymph node dissection in patients with melanoma: A systematic review and individual patient data meta-analysis.
    J Surg Oncol. 2019 Jan 23. doi: 10.1002/jso.25366.
    PubMed     Text format     Abstract available


  11. READ T, Fayers W, Thomas J, Wagels M, et al
    Patients with in-transit melanoma metastases have comparable survival outcomes following isolated limb infusion or intralesional PV-10-A propensity score matched, single center study.
    J Surg Oncol. 2019 Jan 15. doi: 10.1002/jso.25373.
    PubMed     Text format     Abstract available


  12. BRADY MS
    Introduction: Melanoma seminar.
    J Surg Oncol. 2019;119:167.
    PubMed     Text format    


  13. BELLO DM
    Indications for the surgical resection of stage IV disease.
    J Surg Oncol. 2019;119:249-261.
    PubMed     Text format     Abstract available


  14. SPILLANE A, Hong A, Fogarty G
    Re-examining the role of adjuvant radiation therapy.
    J Surg Oncol. 2019;119:242-248.
    PubMed     Text format     Abstract available


  15. RACZ JM, Block MS, Baum CL, Jakub JW, et al
    Management of local or regional non-nodal disease.
    J Surg Oncol. 2019;119:187-199.
    PubMed     Text format     Abstract available


    December 2018
  16. LIU JY, Lowe M
    Neoadjuvant Treatments for Advanced Resectable Melanoma.
    J Surg Oncol. 2018 Dec 27. doi: 10.1002/jso.25352.
    PubMed     Text format     Abstract available


  17. CROMPTON JG, Gilbert E, Brady MS
    Clinical implications of the eighth edition of the American Joint Committee on Cancer melanoma staging.
    J Surg Oncol. 2018 Dec 21. doi: 10.1002/jso.25343.
    PubMed     Text format     Abstract available


  18. HYAMS DM, Cook RW, Buzaid AC
    Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers.
    J Surg Oncol. 2018 Dec 12. doi: 10.1002/jso.25319.
    PubMed     Text format     Abstract available


  19. DESCHNER B, Wayne JD
    Follow-up of the melanoma patient.
    J Surg Oncol. 2018 Dec 12. doi: 10.1002/jso.25324.
    PubMed     Text format     Abstract available


  20. KANG R, Columbo JA, Trooboff SW, Servos MM, et al
    Receipt of sentinel lymph node biopsy for thin melanoma is associated with distance traveled for care.
    J Surg Oncol. 2018 Dec 3. doi: 10.1002/jso.25314.
    PubMed     Text format     Abstract available


    November 2018
  21. BARTLETT EK
    Current management of regional lymph nodes in patients with melanoma.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25316.
    PubMed     Text format     Abstract available


  22. NICOLSON NG, Han D
    Desmoplastic melanoma.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25317.
    PubMed     Text format     Abstract available


  23. KWAK M, Farrow NE, Salama AKS, Mosca PJ, et al
    Updates in adjuvant systemic therapy for melanoma.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25298.
    PubMed     Text format     Abstract available


  24. SONG Y, Karakousis GC
    Melanoma of unknown primary.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25302.
    PubMed     Text format     Abstract available


    September 2018
  25. RONCATI L, Piscioli F
    Clinical decision-making in patients with different histogenetic subtypes of thin melanoma.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25200.
    PubMed     Text format    


  26. NUNES LF, Mendes GLQ, Koifman RJ
    Subungual melanoma: A retrospective cohort of 157 cases from Brazilian National Cancer Institute.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25242.
    PubMed     Text format     Abstract available


  27. BHUTIANI N, Egger ME, Stromberg AJ, Gershenwald JE, et al
    A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph node.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25193.
    PubMed     Text format     Abstract available


  28. KANATSIOS S, Melanoma Project M, Li Wai Suen CSN, Cebon JS, et al
    Neutrophil to lymphocyte ratio is an independent predictor of outcome for patients undergoing definitive resection for stage IV melanoma.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25138.
    PubMed     Text format     Abstract available


  29. ISAKSSON K, Nielsen K, Mikiver R, Nieweg OE, et al
    Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25208.
    PubMed     Text format     Abstract available


    August 2018
  30. LATCHANA N, DiVincenzo MJ, Regan K, Abrams Z, et al
    Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma.
    J Surg Oncol. 2018 Aug 21. doi: 10.1002/jso.25163.
    PubMed     Text format     Abstract available


  31. GONZALEZ AB, Baum CL, Brewer JD, Arpey CJ, et al
    Patterns of failure following the excision of in-transit lesions in melanoma and the influence of excisional margins.
    J Surg Oncol. 2018 Aug 16. doi: 10.1002/jso.25176.
    PubMed     Text format     Abstract available


  32. HEWITT DB, Merkow RP, DeLancey JO, Wayne JD, et al
    National practice patterns of completion lymph node dissection for sentinel node-positive melanoma.
    J Surg Oncol. 2018 Aug 11. doi: 10.1002/jso.25160.
    PubMed     Text format     Abstract available


    June 2018
  33. BEVERIDGE J, Taher M, Zhu J, Mahmood MN, et al
    Staged margin-controlled excision (SMEX) for lentigo maligna melanoma in situ.
    J Surg Oncol. 2018 Jun 24. doi: 10.1002/jso.25109.
    PubMed     Text format     Abstract available


  34. ROBINSON EM, Rosenbaum BE, Zhang Y, Rogers R, et al
    Association between Ki-67 expression and clinical outcomes among patients with clinically node-negative, thick primary melanoma who underwent nodal staging.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25111.
    PubMed     Text format     Abstract available


    April 2018
  35. BOONE BA, Perkins S, Bandi R, Santos E, et al
    Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma.
    J Surg Oncol. 2018;117:940-946.
    PubMed     Text format     Abstract available


  36. POSSO C, Delgado Anaya D, Aguilar Henao J, Velasquez Gaviria JM, et al
    Nasolabial propeller perforator flap: Anatomical study and case series.
    J Surg Oncol. 2018;117:1100-1106.
    PubMed     Text format     Abstract available


    March 2018
  37. READ TA, Smith A, Thomas J, David M, et al
    Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study.
    J Surg Oncol. 2018 Mar 12. doi: 10.1002/jso.24921.
    PubMed     Text format     Abstract available


  38. PUZA CJ, Josyula S, Terando AM, Howard JH, et al
    Does the number of sentinel lymph nodes removed affect the false negative rate for head and neck melanoma?
    J Surg Oncol. 2018 Mar 7. doi: 10.1002/jso.25025.
    PubMed     Text format     Abstract available


  39. PUSIOL T, Piscioli F
    Management of thin melanoma.
    J Surg Oncol. 2018 Mar 6. doi: 10.1002/jso.24863.
    PubMed     Text format    


  40. HUGHES T, Broucek J, Iodice G, Bommareddy PK, et al
    Metastasectomy following incomplete response to high-dose interleukin-2.
    J Surg Oncol. 2018;117:572-578.
    PubMed     Text format     Abstract available


    February 2018
  41. BRANDAO PHDM, Bertolli E, Doria-Filho E, Santos Filho IDAO, et al
    In transit sentinel node drainage as a prognostic factor for patients with cutaneous melanoma.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25023.
    PubMed     Text format     Abstract available


  42. LOOK HONG NJ
    Melanoma patterns of care in Ontario: A call for a strategic alignment of multidisciplinary care-Response to letter.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25006.
    PubMed     Text format    


  43. MARUCCIA M, Elia R, Nacchiero E, Vestita M, et al
    Reply to "melanoma pattern of care in ontario: A call for strategic alignment of multidisciplinary care)".
    J Surg Oncol. 2018 Feb 15. doi: 10.1002/jso.25007.
    PubMed     Text format    


    December 2017
  44. KARYDIS I, Gangi A, Wheater MJ, Choi J, et al
    Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.
    J Surg Oncol. 2017 Dec 28. doi: 10.1002/jso.24956.
    PubMed     Text format     Abstract available


  45. SUN H, Gong L, Zhao G, Zhan H, et al
    Clinicopathological characteristics, staging classification, and survival outcomes of primary malignant melanoma of the esophagus.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24905.
    PubMed     Text format     Abstract available


  46. LOOK HONG NJ, Cheng SY, Baxter NN, Wright FC, et al
    Melanoma patterns of care in Ontario: A call for a strategic alignment of multidisciplinary care.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24936.
    PubMed     Text format     Abstract available


  47. JAKUB JW, Racz JM, Hieken TJ, Gonzalez AB, et al
    Neoadjuvant systemic therapy for regionally advanced melanoma.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24939.
    PubMed     Text format     Abstract available


  48. LORIMER PD, Benham E, Walsh K, Han Y, et al
    Letter response: Reporting of mitotic rate in cutaneous melanoma.
    J Surg Oncol. 2017;116:960.
    PubMed     Text format    


  49. CHU BS, Koffi W, Hoehn RS, Ertel A, et al
    Improvement and persistent disparities in completion lymph node dissection: Lessons from the National Cancer Database.
    J Surg Oncol. 2017;116:1176-1184.
    PubMed     Text format     Abstract available


    November 2017
  50. HERBERT G, Karakousis GC, Bartlett EK, Zaheer S, et al
    Transected thin melanoma: Implications for sentinel lymph node staging.
    J Surg Oncol. 2017 Nov 30. doi: 10.1002/jso.24930.
    PubMed     Text format     Abstract available


  51. DURHAM AB, Schwartz JL, Lowe L, Zhao L, et al
    In reply: Management of thin melanoma.
    J Surg Oncol. 2017 Nov 11. doi: 10.1002/jso.24858.
    PubMed     Text format    


    July 2017
  52. DURHAM AB, Schwartz JL, Lowe L, Zhao L, et al
    The natural history of thin melanoma and the utility of sentinel lymph node biopsy.
    J Surg Oncol. 2017 Jul 17. doi: 10.1002/jso.24765.
    PubMed     Text format     Abstract available


    June 2017
  53. RONCATI L, Piscioli F, Pusiol T
    The importance of mitotic rate reporting in primary cutaneous melanoma.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24738.
    PubMed     Text format    


  54. SUH YC, Suh HP, Lee JS, Chang JS, et al
    Reconstruction using a perforator free flap after malignant melanoma resection of the ankle and foot.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24736.
    PubMed     Text format     Abstract available


  55. ZIPPEL D, Markel G, Shapira-Frommer R, Ben-Betzalel G, et al
    Perioperative BRAF inhibitors in locally advanced stage III melanoma.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24744.
    PubMed     Text format     Abstract available


  56. SINNAMON AJ, Neuwirth MG, Bartlett EK, Zaheer S, et al
    Predictors of false negative sentinel lymph node biopsy in trunk and extremity melanoma.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24743.
    PubMed     Text format     Abstract available


    May 2017
  57. OZAO-CHOY J, Nelson DW, Hiles J, Stern S, et al
    The prognostic importance of scalp location in primary head and neck melanoma.
    J Surg Oncol. 2017 May 22. doi: 10.1002/jso.24679.
    PubMed     Text format     Abstract available


    April 2017
  58. MADU MF, Schopman JHH, Berger DMS, Klop WMC, et al
    Clinical prognostic markers in stage IIIC melanoma.
    J Surg Oncol. 2017 Apr 15. doi: 10.1002/jso.24635.
    PubMed     Text format     Abstract available


    March 2017
  59. LORIMER PD, Benham EC, Walsh K, Han Y, et al
    Reporting of mitotic rate in cutaneous melanoma: A study using the national cancer data base.
    J Surg Oncol. 2017;115:281-286.
    PubMed     Text format     Abstract available


    February 2017
  60. FOOTE M, Read T, Thomas J, Wagels M, et al
    Results of a phase II, open-label, non-comparative study of intralesional PV-10 followed by radiotherapy for the treatment of in-transit or metastatic melanoma.
    J Surg Oncol. 2017 Feb 23. doi: 10.1002/jso.24580.
    PubMed     Text format     Abstract available


    December 2016
  61. SPARKS DS, Read T, Lonne M, Barbour AP, et al
    Primary cutaneous melanoma of the scalp: Patterns of recurrence.
    J Surg Oncol. 2016 Dec 30. doi: 10.1002/jso.24535.
    PubMed     Text format     Abstract available


    September 2016
  62. LEE KT, Kim EJ, Lee DY, Kim JH, et al
    Surgical excision margin for primary acral melanoma.
    J Surg Oncol. 2016 Sep 19. doi: 10.1002/jso.24442.
    PubMed     Text format     Abstract available


  63. DINH KH, Harris AF, LaFemina J, Whalen GF, et al
    Advantages of day-before lymphoscintigraphy and undiluted methylene blue dye injections for sentinel lymph node biopsies for melanoma.
    J Surg Oncol. 2016 Sep 16. doi: 10.1002/jso.24432.
    PubMed     Text format     Abstract available


  64. FAHY AS, Grotz TE, Keeney GL, Glasgow AE, et al
    Frozen section analysis of SLNs in trunk and extremity melanoma has a high false negative rate but can spare some patients a second operation.
    J Surg Oncol. 2016 Sep 16. doi: 10.1002/jso.24430.
    PubMed     Text format     Abstract available


    June 2016
  65. CHANG TN, Lee CH, Lai CH, Wu CW, et al
    Profunda artery perforator flap for isolated vulvar defect reconstruction after oncological resection.
    J Surg Oncol. 2016;113:828-34.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: